
| adamycin |
| la200 |
| (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydro-1,3,12(2H,4H,5H)-tetracenetrione |
| (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[Amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2H,4H,5H)-trione |
| geotilin |
| (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide |
| terramycin dehydrate |
| tetran |
| macocyn |
| EINECS 201-212-8 |
| Oxypan |
| Oxytetracycline |
| (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide |
| oxypam |
| Oxydon |
| 1,3,12(2H,4H,5H)-Naphthacenetrione, 2-(aminohydroxymethylene)-4-(dimethylamino)-4a,5a,6,12a-tetrahydro-5,6,10,11,12a-pentahydroxy-6-methyl-, (2Z,4S,4aR,5S,5aR,6S,12aS)- |
| terramicin |
| (4S,4aR,5S,5aR,6S,12aS)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide |
| MFCD00003700 |
| oxytetracyline |
| Oxytetracyclin |
| tarosin |
| biostat |
| terramycin |
储存于阴凉、通风的库房。远离火种、热源。保持容器密封。应与氧化剂、酸类、碱类等分开存放,切忌混储。采用防爆型照明、通风设施。禁止使用易产生火花的机械设备和工具。储区应备有泄漏应急处理设备和合适的收容材料。
1.由丙烷经硝化而得。先将丙烷放在预热器内于430-450℃进行预热,然后引入内衬玻璃或二氧化硅的反应塔内。反应塔有几处可向内部丙烷气喷注75%硝酸,反应温度调节到390-440℃,压力0.69-0.86MPa,丙烷与硝酸的摩尔比为5:1,由反应塔出来的气体,经冷凝器冷却,硝基丙烷与稀硝酸即凝缩。而丙烷与气态氧化物则由回收塔回收,丙烷循环使用。所得产品为硝基甲烷10%-30%,硝基乙烷20%-25%,1-硝基丙烷25%,2-硝基丙烷40%。该品也可经丙烯硝化得到。2.由丙烯等不饱和烃经气相或液相硝化,或饱和烃液相硝化亦可制得硝基丙烷。
1.由龟裂链霉菌发酵产生,在发酵液中加入碳酸钙,经过滤,将固体干燥而得。
|
土霉素MSDS英文版
|
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危害码 (欧洲) | Xn:Harmful |
| 风险声明 (欧洲) | R36;R63 |
| 安全声明 (欧洲) | S22-S24/25-S36/37/39-S26 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 2 |
| RTECS号 | QI7875000 |